Literature DB >> 1372136

Isolation of canine C-reactive protein and characterization of its properties.

S Yamamoto1, K Tagata, H Nagahata, Y Ishikawa, M Morimatsu, M Naiki.   

Abstract

C-reactive protein (CRP) was isolated from the acute phase serum of dogs subjected to surgical stimulation. Its properties were characterized. Canine CRP was isolated by ion-exchange chromatography using DEAE-Sephacel and DEAE-Sephadex A-50 and affinity chromatography using protein A-Sepharose CL 4B in combination with agar-block electrophoresis. In immunoelectrophoresis, canine CRP had the same gamma-mobility as human gamma-type CRP. The molecular weight of purifined canine CRP was estimated by gel filtration and sodium dodecyl sulfate polyacrylamide gel electrophoresis to be approximately 157,000 and 155,000 respectively. This CRP was a thermolabile protein which completely lost its antigenicity by heating at 70 degrees C for 15 min. The serum concentration of CRP in normal beagle dogs ranged from 0.198 to 0.826 micrograms ml-1 (0.486 +/- 0.170 micrograms ml-1). The concentration was acutely increased by surgery as it was in man and was rapidly decreased with convalescence. Dogs can be a useful animal model for investigation of the mechanism of CRP production and the function of CRP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372136     DOI: 10.1016/0165-2427(92)90103-w

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  19 in total

1.  Preparation of latex sensitized with rabbit IgG antibody for slide reversed passive agglutination.

Authors:  S Yamamoto; K Tagata; Y Ishikawa; H Fujise; H Nagahata; M Yamada; T Sakano; M Morimatsu; M Naiki
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

2.  Quantitative capillary reversed passive latex agglutination test for C-reactive protein (CRP) in the dog.

Authors:  K Tagata; S Yokoyama; T Ginbo; M Honda; T Okimura; M Odakura; M Nomura; S Yamamoto
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

Review 3.  Acute phase response in animals: a review.

Authors:  Carolyn Cray; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

4.  A comparison of the concentrations of C-reactive protein and alpha1-acid glycoprotein in the serum of young and adult dogs with acute inflammation.

Authors:  S Hayashi; T Jinbo; K Iguchi; M Shimizu; T Shimada; M Nomura; Y Ishida; S Yamamoto
Journal:  Vet Res Commun       Date:  2001-02       Impact factor: 2.459

5.  Physiological levels of C-reactive protein in normal canine sera.

Authors:  K Otabe; T Sugimoto; T Jinbo; M Honda; S Kitao; S Hayashi; M Shimizu; S Yamamoto
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

6.  Changes in serum C-reactive protein levels in dogs with various disorders and surgical traumas.

Authors:  S Yamamoto; T Shida; S Miyaji; H Santsuka; H Fujise; K Mukawa; E Furukawa; T Nagae; M Naiki
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

7.  Monitoring C-reactive protein in beagle dogs experimentally inoculated with Ehrlichia canis.

Authors:  T Shimada; Y Ishida; M Shimizu; M Nomura; K Kawato; K Iguchi; T Jinbo
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

8.  Immunological determination of faecal haemoglobin concentrations in dogs.

Authors:  T Jinbo; M Shimizu; S Hayashi; T Shida; T Sakamoto; S Kitao; S Yamamoto
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

9.  C-reactive protein and alpha 1-acid glycoprotein levels in dogs infected with Ehrlichia canis.

Authors:  Y Rikihisa; S Yamamoto; I Kwak; Z Iqbal; G Kociba; J Mott; W Chichanasiriwithaya
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  Canine C-reactive protein (CRP) does not share common antigenicity with human CRP.

Authors:  S Yamamoto; S Miyaji; N Abe; K Otabe; E Furukawa; M Naiki
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.